The U.S. Consumer Product Safety Commission (CPSC) has formally notified DockATot regarding violations of the Infant Sleep Product Rule, stating that the DockATot Deluxe+ is unsafe for infant sleep. In a recent statement, CPSC commissioner Alex Johnson emphasized, “It is hazardous for your baby to sleep in a DockATot Deluxe+;” urging immediate cessation of its use.
The CPSC revealed that DockATot was informed back in June about the need to halt production of the Deluxe+ Dock due to its non-compliance with essential safety standards. This regulation prohibits the sale of products failing to meet safety guidelines established by the CPSC after June 23, 2022. Despite these warnings, DockATot has reportedly continued to import products manufactured post-deadline.
In response, DockATot’s CEO, Jamie Harper, expressed disagreement with the violation notice, claiming the company has not marketed the docks as infant sleep solutions since 2020 and had ceased production of the Deluxe+ earlier this year. Jamie mentioned that DockATot is committed to collaborating with the CPSC to address any issues and feels that their position has been misrepresented.
For those interested in learning more about the risks associated with DockATot products, the CPSC encourages individuals to review incident reports that include accounts of infant deaths linked to these docks. You can also check out this post on the home insemination blog for additional insights. For further information on fertility topics, this resource is highly recommended. Additionally, if you’re looking for excellent guidance on pregnancy and home insemination, visit this page.
In summary, the CPSC has deemed DockATot’s Deluxe+ Dock unsafe for infant sleep, leading to a violation notice due to non-compliance with safety regulations. The company disputes this notice but is open to working with the CPSC to resolve concerns.